Amag wins FDA approval for kidney drug - Bizjournals.com
 Boston Globe | Amag wins FDA approval for kidney drug Bizjournals.com Amag Pharmaceuticals has won Food and Drug Administration approval for its drug to treat chronic kidney disease, called Feraheme. The Lexington, Mass.-based company's drug is applied via an injection and is designed to be used as an iron replacement ... FDA Okays IV Agent to Replace Iron in Chronic Kidney Disease AMAG Pharma shares rise on FDA drug approval FDA approves new IV iron therapy for CKD |
